Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Depreciation and Depletion (2016 - 2025)

SRx Health Solutions (SRXH) has disclosed Depreciation and Depletion for 12 consecutive years, with $500000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Depreciation and Depletion rose 25.0% year-over-year to $500000.0, compared with a TTM value of $590000.0 through Jun 2025, up 5.36%, and an annual FY2025 reading of $100000.0, changed N/A over the prior year.
  • Depreciation and Depletion was $500000.0 for Q2 2025 at SRx Health Solutions, up from $30000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $500000.0 in Q2 2025 and bottomed at $10000.0 in Q3 2024.
  • Average Depreciation and Depletion over 4 years is $102142.9, with a median of $40000.0 recorded in 2022.
  • Peak annual rise in Depreciation and Depletion hit 900.0% in 2024, while the deepest fall reached 75.0% in 2024.
  • Year by year, Depreciation and Depletion stood at $80000.0 in 2022, then changed by 0.0% to $80000.0 in 2023, then plummeted by 37.5% to $50000.0 in 2024, then skyrocketed by 900.0% to $500000.0 in 2025.
  • Business Quant data shows Depreciation and Depletion for SRXH at $500000.0 in Q2 2025, $30000.0 in Q1 2025, and $50000.0 in Q4 2024.